1 ANXIOLYTIC ACTIVITY of Apocynum Venetum L. and ITS
Total Page:16
File Type:pdf, Size:1020Kb
ANXIOLYTIC ACTIVITY OF Apocynum venetum L. AND ITS PROPOSED MECHANISMS OF ACTION By OLIVER GRUNDMANN A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2007 1 © 2007 Oliver Grundmann 2 To all the people who shaped me in so many ways – particular my partner Bob, my father, my aunt, my parents-in-law, and my grandparents. Thank you from the bottom of my heart for all your support and encouragement 3 ACKNOWLEDGMENTS Many people helped in the completion of this thesis in many different ways. I thank my advisor, Dr. Veronika Butterweck, for providing me with the greatest opportunity and challenge of my life – coming over to America. It has profusely changed my life in many ways. Also, I would like to thank Dr. Butterweck for her continued support, providing me with great opportunities, and involving me in research projects besides my dissertation work – I have learned so many things during my studies. I would like to thank my dissertation committee, namely Dr. Hartmut Derendorf, Dr. Guenther Hochhaus, Dr. Cary Mobley, and Dr. Saunjoo Yoon, for their advice and providing me with new input and equipment. Special thanks go to the research groups of Dr. David Rossi, Neurological Science Institute, Oregon Health & Science University, and Dr. Junji Terao, Department of Nutrition, University of Tokushima, for letting me join their research group to conduct research on my project. Especially the group members of Dr. Rossi (David, Claudia, James, and Adrianna) were very welcoming and are now valuable friends as is Dr. Hiroyuki Sakakibara, who helped me in so many ways during my stay in Tokushima. Thanks to Kevin Spelman from the University of North Carolina for analyzing the NMR samples and helping with the identification as well. For their continued financial and personal support I would like to thank Tokiwa Phytochemical Co. LTD and especially Dr. Jun-Ichiro Nakajima, who has provided me with every possible advice and information as well as his personal support, and Mr. Takashi Tatsuzaki, and Dr. Sujiro Seo. All of my lab members and friends were the biggest support throughout my years as a graduate student. Immo, Matt, Yui, Mew, Prajakta, Elanor, Ella, Anna-Maria, Stephan, and Victor have been a great help by being there for professional and personal advice. Without them, this dissertation would probably not have turned out the way it did. Summer students, namely 4 Claire, Andrea, Faryda, and Tanya, have contributed to the success of smaller parts of this work. I thank them for their dedication and hard work. Interns have for sure been a big support for my research. Many thanks go to Katrin, Carmen, Antje, Chris, and Michael for their help with many animal studies and their dedication to the work. Last, but at no means least, I would like to thank my family and friends for their understanding, support, and taking me the way I am. Thank you from the bottom of my heart to my partner Bob for waiting so patiently and endure the separation that followed each of our unities. Thank you to my dad for supporting me and giving me advice if things got rough. Thanks to Michele and Mike for being the best parents-in-law one can wish for. Thanks to my aunt Vera and my grandparents – you made me the person I am today and I am proud to be your child. Thanks to Christel and her parents – you played a major part and shaped my understanding of the world. Friends, who have always been supportive of me and keep in touch no matter what: Arnfried and Alexandra, Dorys, Asha, Roger, Martina, Marisol, Sam and Brian, David, Arielle, Daniela and Nikki, and my brother Mirko and his wife Claudia. 5 TABLE OF CONTENTS page ACKNOWLEDGMENTS.................................................................................................................... 4 LIST OF TABLES................................................................................................................................ 8 LIST OF FIGURES ............................................................................................................................ 10 LIST OF ABBREVIATIONS ............................................................................................................ 13 ABSTRACT ........................................................................................................................................ 14 CHAPTER 1 INTRODUCTION ....................................................................................................... 16 Anxiety Disorders ....................................................................................................................... 16 Epidemiology ....................................................................................................................... 16 Physiology, Pathophysiology, and Pharmacology............................................................. 17 Apocynum venetum...................................................................................................................... 20 Apocynaceae ........................................................................................................................ 20 Apocynum venetum .............................................................................................................. 20 Historic development and taxonomy .......................................................................... 20 Traditional uses and modern indications .................................................................... 23 Known substance classes from Apocynum venetum .................................................. 25 Hypothesis and Specific Aims ................................................................................................... 27 Specific Aim 1 ..................................................................................................................... 28 Specific Aim 2 ..................................................................................................................... 28 Specific Aim 3 ..................................................................................................................... 28 CHAPTER 2 ANALYSIS OF Apocynum venetum EXTRACT AND FRACTIONS ................... 34 Extract Preparation ...................................................................................................................... 34 Extract Analysis .......................................................................................................................... 34 Analytical Equipment .......................................................................................................... 34 Identified compounds from extract..................................................................................... 35 Bioguided Fractionation ............................................................................................................. 35 Preparation of Fractions from Apocynum venetum Extract............................................... 36 Fraction Analysis ................................................................................................................. 37 Preparation of Subfractions of Fraction C from Apocynum venetum ............................... 39 Subfraction Analysis............................................................................................................ 40 Evaluation of Antioxidant Activity ............................................................................................ 42 Conclusions ................................................................................................................................. 45 CHAPTER 3 PHARMACOLOGICAL EVALUATION OF Apocynum venetum AND ITS FRACTIONS ............................................................................................................................... 66 Animal Models ............................................................................................................................ 66 6 Elevated Plus Maze ............................................................................................................. 66 Light-Dark Transition Test ................................................................................................. 68 Stress-Induced Hyperthermia .............................................................................................. 68 Open Field ............................................................................................................................ 69 Evaluation of Anxiolytic-Like Activity of Apocynum venetum ............................................... 70 Elevated Plus Maze ............................................................................................................. 70 Acute anxiolytic effect ................................................................................................. 70 Anxiolytic activity after chronic treatment ................................................................. 73 Light-Dark Transition Test ................................................................................................. 74 Stress-Induced Hyperthermia .............................................................................................. 75 Evaluation of Anxiolytic-like Activity of Fractions prepared from Apocynum venetum ....... 75 Elevated Plus Maze ............................................................................................................